Enhertu completes its front-line march
Astra and Daiichi bag FDA approval based on Destiny-Breast09.
ASCO 2024 – Enhertu nears its “ultralow” dream
But toxicity could hold back Destiny-Breast06's ability to change clinical practice.
Astra and Daiichi bag FDA approval based on Destiny-Breast09.
But toxicity could hold back Destiny-Breast06's ability to change clinical practice.
